Ivosidenib (TIBSOVO®) Combined With Azacitidine According to Current SmPC

Clinical trial NCT06181734 · COMPLETED

Trial details

NCT number: NCT06181734
Sponsor: iOMEDICO AG
Status: COMPLETED
Study type: OBSERVATIONAL

Acute Myeloid Leukemia (AML)

Start date: 2023-12-20
Primary completion: 2025-07-30
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.